Preeclampsia is a multisystem disorder peculiar to human pregnancy. It occurs in 4-5% of all pregnancies and remains a leading cause of maternal and neonatal mortality and morbidity. The pathophysiology of this syndrome is not fully understood. Two stages of vascular dysfunction seem to be involved. In the early stage suboptimal development of the placenta and a hemodynamic maladaptation to pregnancy exist. At this stage maternal constitutional factors such as genetic and immunological factors and pre-existing vascular diseases may play a role. Due to this defective placentation a factor is released from the placenta, supposedly under the influence of ischemia. This factor then results in the late vascular dysfunction characterised mainly by a generalised endothelial dysfunction, leading to the clinical syndrome of preeclampsia. This review attempts to unravel the mechanisms that may contribute to preeclampsia-associated changes in vascular function and to indicate the research needed to improve our understanding of this disease.
Introduction
treatment consists of symptom relief and ultimately delivery. Unravelling the mechanisms causing PE may provide In 4-5% of all human pregnancies preeclampsia (PE) more and better therapeutic options and ultimately a develops. This condition is characterised by an elevated method for prevention of this disease. The purpose of this blood pressure and proteinuria, developing after 20 weeks review is to give an overview of the vascular mechanisms gestational age. PE can result in eclampsia, when convulthat could be involved in the development of PE and to sions develop, or manifest itself as the HELLP syndrome, indicate the research needed to improve our understanding in which Hemolysis, Elevated Liver enzymes and Low of this disease. Platelet count (HELLP) are present. Both conditions are associated with severe complications such as cerebral hemorrhage, lung edema or liver hemorrhage and rupture.
2. Hemodynamic alterations in pregnancy and Moreover women with PE are two and a half times more preeclampsia likely to die from ischemic heart disease later in life [1] . Intrauterine growth restriction and iatrogenic preterm birth Normal pregnancy is associated with extensive anaof the fetus are associated with PE, resulting in a high risk tomical and functional changes of the cardiovascular of early neonatal death and infant mortality or morbidity, system to accommodate the demands of pregnancy. There mainly due to respiratory disease and long term neurologiis a rapid expansion of the total circulating blood volume, cal morbidity [2] .
an increase in heart rate and stroke volume and thus an The mechanisms causing PE are still unclear. Current increase in cardiac output. Blood pressure declines progressively until it reaches its nadir at 20-24 weeks and progressively increases again towards term [3] . Hemo-dynamic adaptation is detectable from early in pregnancy. dysfunction. The disturbed placentation supposedly leads Generalised vasodilatation develops already during the to hypoperfusion of the placenta and ischemia, resulting in luteal phase after conception [4] and peripheral vascular the release of one or more unidentified factors, factor X, resistance falls substantially after 5 weeks gestation, until from the placenta. Factor X then causes the late vascular reaching values 34% lower than preconceptional at 20 dysfunction of PE, consisting mainly of generalised endoweeks [5] . As a result of maternal vasodilatation peripheral thelial dysfunction, resulting in vasoconstriction, activation blood flow increases substantially, primarily in the cutaof the coagulation system and redistribution of fluids, the neous [6], renal [7] and uteroplacental circulation [8] .
symptoms of PE, and often in fetal growth restriction (see Alterations in synthesis of or response to vasoactive Fig. 1 ). substances such as nitric oxide (NO), prostaglandins, endothelin and angiotensin may be involved in the decrease of peripheral resistance in these vascular beds [9] .
Early vascular dysfunction
In PE the hemodynamic and vascular adaptation to pregnancy is disturbed. Of the few studies available on 4.1. Defective placentation early hemodynamic changes in pregnancy one longitudinal study showed that women who subsequently develop PE In early pregnancy trophoblast cells invade the placental have an increased cardiac output throughout pregnancy bed, leading to remodeling of the spiral arteries into [10] . However after development of PE cardiac output has maximally dilated low resistance vascular channels, unable been reported to be decreased [11] , normal [12, 13] or to constrict to vasoactive stimuli [17] , thereby guaranteeincreased [14] . These different findings probably reflect the ing a high flow volume to the uteroplacental bed. In PE heterogeneity of PE [15] . Late hemodynamic changes in trophoblast invasion is impaired and the spiral arteries PE are characterised by increased blood pressure, reduced keep their endothelial lining and musculature. Therefore plasma volume, increased peripheral vascular resistance the vessels remain narrow and reactive. In PE the invasion and vasoconstriction [16] .
is confined to the decidual part of the spiral arteries, while about one third of these arteries completely escapes trophoblast invasion (see Fig. 2 ) [18, 19] . In order to 3. The etiology of preeclampsia answer the question whether the observed abnormal trophoblastic invasion is a primary or secondary phenomThe etiology of PE is still unclear. Early in pregnancy enon to the disease, work on intrinsic defects in trophoblast there is a suboptimal placentation, and an inadequate function (attachment properties, adhesion molecules, enhemodynamic adaptation to pregnancy. Maternal constituzyme secretions, cytokines and growth factors) has become tional factors such as genetic predisposition, immunologiimportant. Zhou et al. found that in PE the invading cal maladaptation to pregnancy and pre-existing vascular cytotrophoblast expresses different adhesion molecules and diseases seem to be involved in this early vascular integrins, thereby failing to adapt its adhesion type from 4.2.2. Immunology one characteristic of trophoblast cells to one characteristic Prior blood transfusion, a prior miscarriage, the practice of endothelial cells [20] . It is also possible that the of oral sex, a longer cohabitation period before conception abnormal trophoblast invasion is a consequence of cytoand immunisation with paternal lymphocytes all reduce the kine (TNF-a) production by activated decidual leukocytes risk for PE. In contrast first pregnancy, change of partner, [21] or altered growth factor production, such as vascular donor insemination and barrier contraceptives all increase endothelial growth factor (VEGF) and placental growth the risk for PE [38, 39] . This strongly suggests that a prior factor [22] . immune response to foreign or paternal antigens protects Based on the above described defective placentation, a against the development of PE. Lymphocytes of women hypoperfusion of the placenta is presumed. While there is with PE do not show the cellular hyporesponsiveness to no substantial evidence for placental hypoxia, in vitro fetal cells that is typical of normal pregnancy [40] , the models show altered cytotrophoblast differentiation at low activity of circulating natural killer cells, neutrophils and oxygen tension [23] and the defects in PE placentas cytokines, such as TNF-a, IL-6, IL-2 and IL-12 is inresemble those seen in hypoxic trophoblast cultures [24] .
creased [38, 39] . In PE HLA-G, a surrogate auto-antigen The structural abnormalities of acute atherosis and placenknown to prevent recognition by natural killer cells [41] , is tal thrombi, seen in the uteroplacental bed of PE prenot expressed as general in the placenta as in normal gnancies, can also contribute to development of hypoxia.
pregnancy [42, 43] . [26] . Early work suggested a single ticardiolipin antibodies and hyperhomocysteinemia recessive gene inheritance, but this model could not [37, 45] . explain all available data [27] . Later both maternal and fetal genotypes were proposed to be responsible for increased susceptibility to PE [28] , partly by the associa-5. Factor X tion between fetal chromosomal abnormalities and PE [29] . More recently it has been suggested that PE is a
To link the placental abnormalities to the generalised polygenic trait, with a strong maternal factor [30] . PE endothelial dysfunction seen in PE, the existence of factor genes probably act as susceptibility loci, lowering the X, released from the placenta into the maternal circulation, threshold for the disease [31] . Implicated in this process was proposed. Indeed, sera of PE patients are toxic to are the angiotensin gene, where the variant cultured endothelial cells [46, 47] , with cytotoxicity disMet235→Thr235 correlates with the risk for PE or rather appearing post partum, consistent with improvement of the hypertension [32] [33] [34] , the endothelial nitric oxide synthase clinical condition [46] . The factor seems to modulate gene on chromosome 7, associated with familial preendothelial cell function rather than damage the cells. In gnancy-induced hypertension [35] and genes involved in response to PE serum / plasma, PGI [48] and NO [49] 2 TNFa-production [36] , thrombophilic disorders, such as production are altered, triglycerides accumulate intracelluthe factor V Leiden mutation (1691 G→A) [31] and larly [50] , cellular permeability is increased [51] and hyperhomocysteinemia, hypertension and obesity [37] .
endothelium-dependent dilatation in isolated arteries is Thus far most studies investigating the role of genetics in diminished [52] . Initially factor X was thought to be a PE have been small scale and a large database of genosingle factor, but increasing evidence suggests the presence types, present in women with PE and their children, is of several interacting factors, which might also explain the needed to elucidate to which extent genetics are involved heterogeneity of the PE manifestations. in PE.
Among the candidate factors are syncytiotrophoblast microvillous membrane particles (STBM). Syncytiotacid oxidation and ketogenesis [39] . An interesting finding rophoblast is the outer layer of the placenta with countless in this respect is the increased incidence of HELLP (15%) microvilli on its surface, that forms the contact with found when the fetus is homozygous or compound heteromaternal blood. PE placentas show abnormally shaped zygous for Glu474Gln causing long-chain 3-hydroxyacylmicrovilli and areas of focal necrosis [53] , changes similar coenzyme A dehydrogenase deficiency (LCHAD), a geto those induced by hypoxia in cultured placental villi [54] .
netic disorder affecting fatty acid b-oxidation [74] . This Whole trophoblast cells are shed into the maternal circulacould be due either to the obligate heterozygosity of the tion in pregnancy [55] . This deportation is exaggerated in mother for LCHAD mutations, which can cause decreased PE [56] . Likewise, the plasma STBM concentration is fatty acid b-oxidation, and thus to an increase in plasma increased in PE [57] . STBM interfere with growth of fatty acids, as has indeed been found in PE [75] or to cultured endothelial cells, irrespective of whether a PE or accumulation of long-chain 3-hydroxyacyl metabolites normal placenta is used for STBM preparation [58] .
produced by fetus or placenta. The importance of the latter Perfusion of isolated subcutaneous arteries with a very factor might be minor however, since ante partum fatty high STBM concentration caused abolishment of acetylacid b-oxidation in the fetus is limited and most energy is choline-mediated vasodilatation [59] . In a recent study, supplied by glucose transport from the mother [74] . however, we demonstrated that STBM in concentrations found in vivo in PE patients have no effect on bradykininmediated dilatation in isolated myometrial arteries (un-6. Late systemic vascular dysfunction published observations). Therefore the involvement of STBM as factor X in PE remains unclear.
6.1.1. The endothelium Factor X could also be oxidative stress. Activated decidual large granulocytes produce cytokines, proteases
The endothelium plays a major role in the vascular and oxygen free radicals. When oxygen free radicals are changes in pregnancy. The endothelium appears to be not eliminated by antioxidants, lipid peroxide formation is upregulated in pregnancy, producing vasodilatation either induced [60] . All these substances can cause endothelial as a result of an increased release of vasodilators or a damage [61] . Indeed several authors reported increased decreased vasoconstrictor output [9] . In PE there is overlevels of lipid peroxidation products in PE in blood and whelming evidence for endothelial dysfunction [76, 77] . decidua basalis [62] [63] [64] and PE placentas produce more Morphological evidence includes glomerular endotheliosis, lipid peroxides than control placentas [60] . Antioxidant with swollen endothelial cells in the glomeruli, which levels, such as thiols [65] , vitamin E, C and carotenoids could cause hypoperfusion of the kidney and protein [66] are all decreased in PE. Moreover superoxide dismutleakage [78] . Structural changes of the endothelium have ase was decreased in neutrophils [67] and placentas [68] of also been found in the uteroplacental vessels [79] . In women with PE. STBM and oxidative stress could be addition extensive evidence exists for functional disorders potentiating each others effects. When cultured endothelial of the endothelium. The concentrations of Von Willebrand cells are incubated with STBM, a substance is produced factor, endothelin, fibronectin and several cell adhesion that activates peripheral leukocytes and primes monocytes molecules are increased and there is a change in balance to respond stronger upon activation [69] . Chappell et al. between tissue plasminogen activator and inhibitor and recently showed that treatment of women at increased risk between PGI and TxA , all indicating endothelial cell 2 2
for PE with high dose vitamin C and E from 16 to 22 activation [76] . Vascular tone and thus peripheral resistance weeks of gestation onwards decreases their risk to develop are known to be under continuous influence of endo-PE. Larger trials are needed to confirm this and to choose thelium derived factors. Consequently the altered state of the right moment to start, the optimum dose and type of the endothelium in PE has major consequences for the antioxidants [70] .
regulation of tone. The mechanisms for endothelium-deAnother possibility for factor X relates to the lipid pendent vasodilatation and vasoconstriction and the vasmetabolism. In PE lipid levels are increased even more oactive substances implicated to be involved in PE will be than in normal pregnancy [71] . Incubation of endothelial discussed below. Table 1 gives a summary of vasoactive cells with PE sera increased their triglyceride content and substances whose altered productions have been implicated reduced thrombin-stimulated PGI release in one study 2 in PE. [50] , although this could not be confirmed by others [72] . Endothelial cells incubated with fatty acids show impaired endothelial PGI and NO production [73] . Thus, an altered 6.1.2. Endothelium-dependent vasodilatation 2 fat metabolism can cause functional changes of the endoInvestigations in isolated arteries have yielded some thelium. The alterations in the lipid metabolism in PE direct evidence for vascular endothelial dysfunction in PE could be caused by cytokines, like TNF-a, IL-1 and IL-6, and generally agree that endothelium-dependent dilatation that are lipolytic in adipocytes, by promotion of de novo is impaired in PE [80] [81] [82] [83] . The endothelium-derived hepatic fatty acid synthesis and impairment of hepatic fatty vasodilatory substances PGI , NO and endothelium de- a potent vasoconstrictor and platelet aggregator, produced role for NO in PE at least in the uteroplacental circulation, mainly by platelets and to a lesser degree by endothelium.
although it remains unclear whether this is just symptom A reduced PGI production can cause an increased TxA relief or there is an etiological role for NO.
2 2 concentration due to platelet aggregation. Indeed, urinary Recently the presence of a vasodilatory substance, TxA metabolites are increased in PE [85] and correlate produced by the endothelium and acting by hyperpolaris-2 with disease severity [88] . A reduced PGI / TxA ratio, ing vascular smooth muscle cells, EDHF, has been discov-2 2
found in blood, cytotrophoblast [89] and placental extracts ered [105] . It has been suggested that EDHF is a cyto- [90] of PE patients, was thus proposed to cause the chrome P450-derived arachidonic acid product [106] or an vasoconstriction in PE. Although most studies have indeed endogenous cannabinoid [107] . In resistance arteries of found evidence for an imbalance in the PGI / TxA ratio, normal pregnant and women with PE endothelium-depen-2 2 restoration of the PGI / TxA ratio with low dose aspirin dent dilation was attenuated despite blockade of pros- 2 2 hardly prevents the development of PE, indicating that the tanoids and NO, suggesting a role for EDHF [108] . Further PGI / TxA mechanism is not the only mechanism inresearch is needed to identify EDHF and to elucidate its 2 2
volved [91] . role in PE. The vasodilatory responses to endothelium-dependent agonists such as acetylcholine and bradykinin are impaired 6.1.3. Endothelium-dependent vasoconstriction in isolated arteries from women with PE [80] [81] [82] [83] . AlEndothelin, a vasoconstrictive substance produced by though NO plays a dominant role in these responses the endothelium, has been implicated in the pathogenesis current evidence related to the involvement of NO in PE of PE. Plasma endothelin concentrations appear to be remains controversial, with studies favouring [81, 82] and elevated in PE [109] [110] [111] [112] [113] , although there is a substantial challenging [83] it. Not only data concerning vascular overlap with normal values. Uterine vein endothelin levels responses to bradykinin and acetylcholine are conflicting, were three times higher in PE, indicating a role for also levels of NO metabolites were found lower [92] , endothelin in the decreased uteroplacental blood flow similar [93] [94] [95] or even increased [96] [97] [98] in PE, whereas [110] . Incubation of endothelial cells with PE serum sera from PE pregnancies were found to increase nitric suppresses endothelin production. This may however be oxide synthase activity in endothelial cell cultures [49] .
caused by a factor in the serum, released in response to the The concept of NO deficiency in PE therefore remains elevated endothelin concentrations [114] . Endothelin-incontroversial. The predominant physiological stimulus for duced constriction was similar in PE and normal pregnant endothelial NO synthesis is shear stress [99] . Flow-induced patients in isolated myometrial arteries but enhanced in omental arteries [90, 115, 116] . This could be explained by This increased pressor response may be due to altered receptor down-regulation in uteroplacental circulation in numbers of AII receptors or altered affinity of the receptor response to the increased concentrations. The role of [136] . Since prostacyclin is one of the factors regulating endothelin in PE, thus, seems to be restricted to the renin release, the reduced prostacyclin production in PE uteroplacental circulation.
can be the cause of the reduced AII concentrations, which could result in upregulation of receptors and sensitivity.
Circulating vasoactive substances
Therapy with angiotensin converting enzyme inhibitors however is not a possibility in pregnancy since they are Atrial natriuretic peptide (ANP) is a vasodilatory hortoxic to the fetus [138] . However the link of the AII gene mone produced mainly in the atrial myocytes in response to hypertension suggests involvement of the angiotensin to wall stretch and in the placenta. In PE plasma ANP system already in the early phase of PE. Agonistic autolevels have been found to be increased [117] . ANP antibodies to the AII receptor have been observed in PE opposes the vasoconstrictive action of endothelin [118] and [137] . These auto-antibodies could only be detected shortly angiotensin [119] , and induces vasodilatation in the uteropbefore development of clinical symptoms, suggesting them lacental vasculature of women with PE as well as a small to play a role in the late rather than the early phase of PE. reduction in blood pressure [120] .
Enhanced pressor responses are not unique to AII, but are More recently VEGF was proposed to be involved in PE also seen in vivo to norepinephrine [139] and in vitro, in (see [121] . VEGF is not only involved in vascular growth, isolated arteries, to vasopressin and prostaglandin F 2a but also has a vasoactive effect and causes increased [140] . vascular permeability. Circulating levels of VEGF were
Furthermore an enhanced pressure-induced myogenic found to be elevated [122] [123] [124] [125] and correlated to blood tone was found [82] . This could be due not only to the pressure in patients with PE [123] , although others found increased sensitivity to vasopressors and the endothelial decreased concentrations [126, 127] . The observed dedysfunction, but also to an increased activity of the creased concentrations could however be due to the use of sympathetic nervous system or an altered calcium sena detection technique, in which VEGF binding proteins sitivity of the contractile apparatus. The sympathetic interfere, thereby disabling detection of bound VEGF nervous system can control vascular tone by releasing [128] . VEGF was not detectable before the onset of clinical catecholamines that can induce vascular smooth muscle symptoms [122] . The source of the increased VEGF in PE contraction. Research first focussed on circulating catis unclear. VEGF is expressed in the placenta [129] and echolamine concentrations, but results were conflicting, trophoblast cells cultured under hypoxic conditions show and it is now accepted that this is an insensitive method of increased VEGF production [130] . However, VEGF measuring sympathetic activity. Schobel et al. measured mRNA expression in placental tissue decreases with sympathetic nerve activity of fibers innervating blood increasing gestation and is even further decreased in PE vessels in skeletal muscle and found an increased sympa- [131] . VEGF might also be released by aggregating thetic activity in PE [141] . The fact that age-matched non platelets [132] and vascular smooth muscle cells [133] .
pregnant hypertensive women did not show any increase in Increased VEGF concentrations could contribute to the sympathetic activity, indicates that the changes found in extravasation of plasma proteins and subsequent develop-PE are specific to the disease rather than secondary to high ment of proteinuria, both characteristic features of PE.
blood pressure [141] . The mechanisms underlying this Hayman et al. reported that VEGF impairs endotheliumincreased sympathetic activity are unclear. The increase is dependent dilatation to levels similar to those obtained in not linked to heart rate or baroreceptor-mediated feedback arteries of women with PE. This response was largely on central sympathetic outflow. However the role of reversed by incubation with antibody to VEGF [121] .
humoral and paracrine factors, influencing the central Confirmation of these findings and further research into the nervous system has not yet been investigated [141] . The origin of the increased VEGF concentration and its mechafact that methyldopa, a centrally acting drug, reducing nism of action in PE is needed to develop therapeutic sympathetic outflow, is the drug of choice for longer term strategies directed against this substance.
blood pressure control in PE indicates the involvement of this system in PE [141] . However with progression of the 6.2.1. Vascular smooth muscle disease additional medication is usually required indicating The increased vascular resistance in PE is closely related other systems to be involved. An increased calcium to an increased responsiveness to vasopressors. While sensitivity can be caused by various substances through angiotensin (AII), as well as the active renin and aldosseveral pathways [142] . On the other hand, endothelium terone concentrations [134] , is decreased in PE, the can reduce calcium sensitivity by NO production. In PE, sensitivity of the vasculature to AII is increased. Women where the endothelium is dysfunctional and the sensitivity who subsequently develop PE lose their resistance to AII to vasopressors changed, this could result in an increased as early as gestational week 23, and become even more smooth muscle calcium sensitivity. We have indeed found sensitive to AII near term then non pregnant women [135] .
the increased vascular tone in PE to be associated with an increased sensitivity of subcutaneous arteries to intracelluprimary events will become available in the near future. lar calcium (unpublished observations). From this perspecUntil then treatment should be aimed at reduction or tive modulators of calcium sensitivity can in the future prevention of endothelial damage. Elucidating the mechaprovide us with a more accurate therapy for PE.
nisms involved in this damage obviously would improve It should be kept in mind that the increased peripheral our chances of finding effective treatment strategies. Based resistance in PE can be the result of either vasoconstricon the evidence that oxidative stress and free radical tion, due to an altered production of or sensitivity to formation are increased in PE, treatment with antioxidants vasoactive substances, inward vascular remodeling, or might prove worthwhile, and indeed such trials are in even rarefaction (i.e. the disappearance of arterioles).
progress and promising. The possibilities for correction of Concerning remodeling, the observed greater media thickhyperlipidemia also need to be studied. If indeed a role for ness to lumen diameter ratio in omental arteries of PE STBM can be established, therapies could be developed to patients indeed indicates an altered wall structure [143] , remove these particles from the circulation or to prevent although it remains unclear whether this represents an their damaging effect. The finding of impaired shearadaptation to the increased pressure or is a cause of mediated NO release in isolated arteries in PE suggests increased blood pressure. Recent in vitro work showed that that increasing NO in circulation with NO donors or the arteriolar remodeling can occur within a period of 3 days substrate for NO, L-arginine, may prove to be a successful [144] . This rapid alteration in arteriolar structure allows a treatment strategy. Confirmation of the results reported by role for remodeling in the increased peripheral resistance Hayman et al. on the role of VEGF in PE [121] is required. in PE and in its fast reversal after delivery.
If VEGF is indeed involved, therapeutic use of heparin should be reconsidered, since heparin is known to strongly bind VEGF. The option of intervention at the level of 7. Conclusions and future perspectives vascular smooth muscle cells is insufficiently explored. From this perspective calcium sensitivity modulators form The multitude of systems involved in the pathophysiola new group of possible therapeutic agents. ogy of PE and their complex interactions provide an intriguing challenge. It is essential to clarify the mechanisms involved in early and late vascular dysfunction and Acknowledgements to identify the factor(s) connecting them in order to understand, treat and eventually prevent PE. There are
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placentation, where the roots of PE seem to be, is required 
